Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients

Name: Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients
License: Public Domain

Yonsei University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

antineoplastic-agents breast-neoplasms polymorphism survival-analysis

breast neoplasms, survival analysis, antineoplastic agents, therapeutic uses, tamoxifen, cytochrome p-450 cyp2d6, polymorphism, single nucleotide, antineoplastic agents, hormonal, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients

Related documents